Financial Toxicity Survey for Myeloma Patients
The PMMNG has supported the University of Pennsylvania Abramson Cancer Center for some time in their development of a survey on the topic of financial toxicity for myeloma patients. The survey is ready now, and we invite you to participate in this study to help our research community better understand the impact of our treatments on the non-medical side of our lives. The study is being led by Christina Bach, Colleen Erb and Dr. Edward Stadtmauer, all of whom have been active with us in the PMMNG.
The recruitment letter for the survey, which provides details about how to participate in the survey, is attached below.